Clinical

Articles

The findings were similar in people with or without diabetes.

Analysis Finds Farxiga a Cost-effective Addition for Some Patients with Heart Failure

Competition among branded products did not substantially curb annual spending increases.

Study: Branded Direct Oral Anticoagulants Raised Medicare Part D Spending


Angiotensin receptor blockers may be less likely to cause side effects than ACE inhibitors.


Study: Blood Pressure Meds Work Equally, But One Has Fewer Side Effects

Most of the suspected cases of myocarditis developed after the second dose of the vaccine and were among younger males.

COVID-19 Vaccine Benefits Outweigh Low Risk of Developing Myocarditis, Study Finds

This research sought to understand the relationship of prior medication exposure, existing health conditions, and COVID-19 outcomes using data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry.

Study: Statins Reduce Death Rate in Patients with COVID-19

New data show efficacy in all forms of heart failure regardless of ejection fraction.


Jardiance First to Reduce Risk of Death in Heart Failure Patients 


Adults taking medications that cross the blood-brain barrier had better memory recall.


Certain Blood Pressure Meds Improve Memory

Chances of left ventricular ejection fraction almost disappeared when patient took the ACE-inhibitor lisinopril during treatment with trastuzumab/anthracycline, according to research presented at ASCO.










Reducing Cardiac Toxicity During Cancer Treatment

The AstraZeneca drug is the first SGLT2 inhibitor approved for chronic kidney disease regardless of whether the patient  has diabetes.

Blockbuster Farxiga Gets New Chronic Kidney Disease Indication 

Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin. 